214680.KQ
DRTECH Corporation
KOE · Healthcare · Medical - Specialties · KR
KRW 960.00
−10.28%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 126.2B | 116.3B | 97.6B | 92.4B | 89.5B |
| Cost of Revenue | 79.3B | 79.4B | 58.0B | 50.1B | 49.2B |
| Gross Profit | 47.0B | 36.9B | 39.5B | 42.3B | 40.3B |
| Operating Expenses | |||||
| R&D Expense | 17.7B | 16.2B | 16.9B | 11.5B | 10.8B |
| SG&A Expense | 25.4B | 15.1B | 11.7B | 11.3B | 9.7B |
| General & Admin Expense | 5.1B | 6.6B | 4.3B | 5.7B | 5.0B |
| Selling & Marketing Expense | 8.6B | 8.5B | 7.4B | 6.5B | 4.8B |
| Other Expenses | 13.8B | 19.6B | 23.1B | 19.7B | 12.1B |
| Total Operating Expenses | 57.0B | 50.8B | 51.6B | 42.5B | 32.7B |
| Cost and Expenses | 135.1B | 130.2B | 109.7B | 92.6B | 84.6B |
| Operating Income (EBIT) | (10.0B) | (13.9B) | (12.1B) | (148.8M) | 4.9B |
| Non-Operating | |||||
| Interest Income | 4.1B | 493.6M | 741.4M | 901.0M | 503.3M |
| Interest Expense | 14.6B | 8.0B | 4.4B | 2.0B | 1.4B |
| Net Interest Income | (10.5B) | (7.5B) | (3.7B) | (1.1B) | (856.2M) |
| Other Non-Op Income/Expense | (4.4B) | (11.8B) | (6.7B) | (703.2M) | 312.2M |
| Non-Operating Income (excl Interest) | — | — | 2.3B | (1.3B) | 2.7B |
| EBT (Pre-Tax Income) | (14.4B) | (25.7B) | (18.8B) | (852.0M) | 5.2B |
| Income Tax Expense | 1.6B | (1.7B) | 530.1M | 1.2B | (722.1M) |
| Bottom Line | |||||
| Net Income | (12.5B) | (24.0B) | (19.3B) | (2.2B) | 6.0B |
| Earnings from Cont. Ops | (12.5B) | (24.0B) | (19.3B) | (2.1B) | 5.9B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (12.5B) | (24.0B) | (19.3B) | (2.2B) | 6.0B |
| Per Share | |||||
| Basic EPS | (₩143) | (₩321) | (₩592) | (₩34) | ₩103 |
| Diluted EPS | (₩147) | (₩321) | (₩592) | (₩34) | ₩96 |
| Revenue Per Share | ₩1,222 | ₩1,556 | ₩2,997 | ₩1,398 | ₩1,543 |
| Shares | |||||
| Basic Shares Outstanding | 103.3M | 74.7M | 32.6M | 66.1M | 58.0M |
| Diluted Shares Outstanding | 103.3M | 74.7M | 32.6M | 66.1M | 62.2M |
| Profitability Metrics | |||||
| EBITDA | 1.2B | (2.9B) | (4.4B) | 9.1B | 11.4B |
| D&A | 11.3B | 11.1B | 10.0B | 8.0B | 6.5B |
| EBIT | (10.0B) | (13.9B) | (14.4B) | 1.1B | 4.9B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026